(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMTALK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMTALK

ST13

US500000087377601

Class

41

Filing

87377601

Registration

5398325

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

08/22/2024

Trademark type

Word

Nice classes

41

Filing date

03/20/2017

Registration date

02/06/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/22/2024

Last transaction

08/22/2024

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

12/01/2016

First use in commerce

12/01/2016

Drawing code

4

Owner type

99

Owner location

Washington, DC

Examiner

MALASHEVICH, JASON

Current location

Historical data usage

Holders and representatives

Holders

American Pharmacists Association (APhA)

Representatives

Gregory M. Stone WHITEFORD, TAYLOR & PRESTON, LLP

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Educational servicesthe presentation of seminarslecturesworkshops and panel discussions in the field of pharmaceutical and medical practice

Publications

History of USPTO decisions and trademark events.

20 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

08/22/2024

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

08/22/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/22/2024

ES8R

TEAS SECTION 8 RECEIVED

02/06/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/06/2023

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

02/06/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/02/2018

ALIE

ASSIGNED TO LIE

12/26/2017

ALIE

ASSIGNED TO LIE

12/15/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

11/30/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/29/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/29/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/30/2017

GNRT

NON-FINAL ACTION E-MAILED

05/30/2017

CNRT

NON-FINAL ACTION WRITTEN

05/30/2017

DOCK

ASSIGNED TO EXAMINER

05/25/2017

MPMK

NOTICE OF PSEUDO MARK E-MAILED

03/24/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/23/2017

NWAP

NEW APPLICATION ENTERED

03/23/2017

Continuous trademark protection

Get notified about every new filing that threatens PHARMTALK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.